Received: 30 September 2020
Accepted: 29 January 2021
First Online: 31 March 2021
: The medical ethics testing committee Erasmus MC has approved the ethicality of the study under reference MEC-2014-455. All the procedures and methods have been performed according to the guidelines of the ethics committee and in accordance with local laws and regulations. All participants were informed of the study contents and signed an informed consent form before inclusion into the study.
: Not applicable.
: The authors would like to state a number of competing interests. The author AEB is co-founder of InBiome B.V. and together with author PHMS co-inventer of the IS-pro technology. The authors LP and MPB report that they are employees at Inbiome B.V., the authors RK and JDdJ report that they are an employee at ARTPred B.V.. JSEL reports consultancy fees from Titus Health Care. The Authors MS, SS and SAM declare that there is no conflict of interest.JDdJ and AEB have obtained patents ‘Microbial population analysis’ (9506109) and ‘Microbial population analysis’ (20170159108), both licenced to ARTPred B.V.. JDdJ and AEB report patent applications ‘Method and kit for predicting the outcome of an assisted reproductive technology procedure’ (392EPP0) and patent ‘Method and kit for altering the outcome of an assisted reproductive technology procedure’ by ARTPred.